Showing 5 posts of 5 posts found.

FDA approves Innoviva’s Xacduro for intravenous use

May 24, 2023
Medical Communications FDA, Infections and infestations, Innoviva, pneumonia

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, has announced that the US Food and Drug Administration (FDA) has approved Xacduro …


Top Ten most popular articles on this week!

May 10, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, GSK, Innoviva, NHS, Novartis, health, migraine, pharma

This week was a particularly bad one for the NHS after it was revealed thousands of EU nurses were leaving …


GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3

May 3, 2019
Medical Communications, Research and Development GSK, Innoviva, Trelegy, ellipta, pharma

GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …


GSK 18 months ahead of the game with three-drug inhaler

November 21, 2016
Medical Communications, Sales and Marketing GSK, Innoviva, chronic obstructive pulmonary disease

GlaxoSmithKline, alongside its partner Innoviva, have filed a regulatory submission with the FDA for its treatment for chronic obstructive pulmonary …


GSK announce positive results for chronic obstructive pulmonary disease treatment

September 5, 2016
Manufacturing and Production, Research and Development, Sales and Marketing GlaxoSmithKline, Innoviva, Revlar Ellipta, chronic obstructive pulmonary disease

GlaxoSmithKline and its partner Innoviva have announced that its Relvar Ellipta achieved positive results in its COPD Salford lung study …

Latest content